Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: A serial intravascular ultrasound analysis

Korean Journal of Internal Medicine

Volumn 25, Issue 4, 2010, Pages 356-363

  Hong, Young Joon ^a   Jeong, Myung Ho ^a   Choi, Yun Ha ^a   Ma, Eun Hye ^a   Ko, Jum Suk ^a   Lee, Min Goo ^a   Park, Keun Ho ^a   Sim, Doo Sun ^a   Yoon, Nam Sik ^a   Youn, Hyun Ju ^a   Kim, Kye Hun ^a   Park, Hyung Wook ^a   Kim, Ju Han ^a   Ahn, Youngkeun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Atherosclerosis; Interventional; Lipids; Plaque; Ultrasonography

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARE METAL STENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; METALS; MIDDLE AGED; RETROSPECTIVE STUDIES; SIMVASTATIN; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 78650979976     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2010.25.4.356     Document Type: Article

References (16)

1. Hoffmann R, Mintz GS, Popma JJ, et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol 1996;28:1134-1139.
2. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
3. Mudra H, Regar E, Klauss V, et al. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. Circulation 1997;95:363-370.
4. Weissman NJ, Wilensky RL, Tanguay JF, et al. Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol 2001;88:248-252.
5. Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol 2006;47:2172-2179.
6. Serruys PW, Degertekin M, Tanabe K, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004;109:627-633.
7. Honda Y, Grube E, de La Fuente LM, Yock PG, Stertzer SH, Fitzgerald PJ. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2- eluting polymer stent system. Circulation 2001;104:380-383.
8. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
9. Hong YJ, Jeong MH, Lim JH, et al. The prognostic significance of statin therapy in acute myocardial infarction patients underwent percutaneous coronary intervention. Korean J Med 2003;65:426-435.
10. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080.
11. Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 2003; 91(4A):4B-8B.
12. Corsini A, Mazzotti M, Raiteri M, et al. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 1993;101:117-125.
13. Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997;350:1217-1219.
14. Suzuki M, Saito M, Nagai T, Saeki H, Kazatani Y. Prevention of positive coronary artery remodeling with statin therapy in patients with coronary artery diseases. Angiology 2006;57:259-265.
15. Jensen LO, Thayssen P, Mintz GS, Carlier SG, Pedersen KE, Haghfelt T. Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study. Cardiology 2006;106:256-263.
16. Petronio AS, Amoroso G, Limbruno U, et al. Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. Am Heart J 2005;149:520-526.